Findings from Center for Disease Control and Prevention Provides New Data about Antiretrovirals (Factors Associated with Antiretroviral Therapy…

Findings from Center for Disease Control and Prevention Provides New Data about Antiretrovirals (Factors Associated with Antiretroviral Therapy Adherence Among Transgender Women Receiving HIV Medical Care in the United States)

By a News Reporter-Staff News Editor at Insurance Weekly News -- A new study on Drugs and Therapies - Antiretrovirals is now available. According to news reporting originating in Atlanta, Georgia, by VerticalNews journalists, research stated, "We examined factors associated with antiretroviral therapy (ART) adherence among transgender women living with HIV (TWLWH). We used combined data from the 2009 to 2013 cycles of Medical Monitoring Project, an HIV surveillance system designed to produce nationally representative estimates of the characteristics of HIV-infected adults receiving HIV medical care in the United States."

The news reporters obtained a quote from the research from Center for Disease Control and Prevention, "Rao-Scott chi-square tests and multivariable logistic regression were used to identify factors associated with dose adherence (defined as taking 100% of prescribed ART doses in the past 3 days). Among TWLWH who reported current ART use, an estimated 80.5% self-reported dose adherence. Multivariable factors independently associated with lower (<100%) dose adherence were younger age (30-39 vs. 40 and over), not having health insurance coverage, depression, lower self-efficacy to take medication as prescribed, and having greater than one daily ART dose."

According to the news reporters, the research concluded: "Our findings suggest several ways to potentially improve ART adherence of TWLWH including tailoring efforts to address the needs of TWLWH under age 40, increasing access to health insurance coverage, addressing mental health morbidities, building skills to improve medication adherence self-efficacy, and simplifying ART regimens when possible."

For more information on this research see: Factors Associated with Antiretroviral Therapy Adherence Among Transgender Women Receiving HIV Medical Care in the United States. LGBT Health, 2017;4(3):181-187. LGBT Health can be contacted at: Mary Ann Liebert, Inc, 140 Huguenot Street, 3RD Fl, New Rochelle, NY 10801, USA.

Our news correspondents report that additional information may be obtained by contacting Y. Mizuno, Center Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30329, United States. Additional authors for this research include L. Beer, P. Huang and E.L. Frazier.

Keywords for this news article include: Atlanta, Georgia, United States, North and Central America, Viral Sexually Transmitted Diseases and Conditions, Immune System Diseases and Conditions, Health Insurance, Epidemiology, Primate Lentiviruses, Drugs and Therapies, Vertebrate Viruses, Antiretrovirals, Retroviridae, RNA Viruses, HIV/AIDS, Therapy, Center for Disease Control and Prevention.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC